460 related articles for article (PubMed ID: 11063720)
1. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
Unterrainer G; Molzer B; Forss-Petter S; Berger J
Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
[TBL] [Abstract][Full Text] [Related]
3. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
4. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.
Feigenbaum V; Lombard-Platet G; Guidoux S; Sarde CO; Mandel JL; Aubourg P
Am J Hum Genet; 1996 Jun; 58(6):1135-44. PubMed ID: 8651290
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of ALDP in X-linked adrenoleukodystrophy.
Watkins PA; Gould SJ; Smith MA; Braiterman LT; Wei HM; Kok F; Moser AB; Moser HW; Smith KD
Am J Hum Genet; 1995 Aug; 57(2):292-301. PubMed ID: 7668254
[TBL] [Abstract][Full Text] [Related]
6. ALDP expression in fibroblasts of patients with X-linked adrenoleukodystrophy.
Kemp S; Mooyer PA; Bolhuis PA; van Geel BM; Mandel JL; Barth PG; Aubourg P; Wanders RJ
J Inherit Metab Dis; 1996; 19(5):667-74. PubMed ID: 8892025
[TBL] [Abstract][Full Text] [Related]
7. Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange.
Dvoráková L; Storkánová G; Unterrainer G; Hujová J; Kmoch S; Zeman J; Hrebícek M; Berger J
Hum Mutat; 2001; 18(1):52-60. PubMed ID: 11438993
[TBL] [Abstract][Full Text] [Related]
8. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
[TBL] [Abstract][Full Text] [Related]
9. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
[TBL] [Abstract][Full Text] [Related]
10. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
Takahashi N; Morita M; Imanaka T
Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
[TBL] [Abstract][Full Text] [Related]
11. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
12. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
[TBL] [Abstract][Full Text] [Related]
13. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes.
Contreras M; Sengupta TK; Sheikh F; Aubourg P; Singh I
Arch Biochem Biophys; 1996 Oct; 334(2):369-79. PubMed ID: 8900413
[TBL] [Abstract][Full Text] [Related]
14. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
[TBL] [Abstract][Full Text] [Related]
15. X-linked adrenoleukodystrophy: phenotype distribution and expression of ALDP in Spanish kindreds.
Ruiz M; Coll MJ; Pàmpols T; Girós M
Am J Med Genet; 1998 Apr; 76(5):424-7. PubMed ID: 9556303
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
Braiterman LT; Watkins PA; Moser AB; Smith KD
Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
[TBL] [Abstract][Full Text] [Related]
18. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
20. Adrenoleukodystrophy: the restoration of peroxisomal beta-oxidation by transfection of normal cDNA.
Shinnoh N; Yamada T; Yoshimura T; Furuya H; Yoshida Y; Suzuki Y; Shimozawa N; Orii T; Kobayashi T
Biochem Biophys Res Commun; 1995 May; 210(3):830-6. PubMed ID: 7763255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
